Nuveen LLC bought a new stake in shares of Quantum-Si Incorporated (NASDAQ:QSI - Free Report) in the first quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor bought 319,100 shares of the company's stock, valued at approximately $383,000. Nuveen LLC owned about 0.17% of Quantum-Si at the end of the most recent quarter.
Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. WestHill Financial Advisors Inc. purchased a new position in Quantum-Si during the first quarter valued at approximately $26,000. HBW Advisory Services LLC purchased a new position in shares of Quantum-Si during the 1st quarter valued at $29,000. Balyasny Asset Management L.P. purchased a new position in shares of Quantum-Si during the 4th quarter valued at $36,000. Cetera Investment Advisers bought a new position in Quantum-Si in the 4th quarter worth $36,000. Finally, Wealth Enhancement Advisory Services LLC purchased a new stake in Quantum-Si in the 4th quarter worth $36,000. 39.90% of the stock is owned by hedge funds and other institutional investors.
Insider Buying and Selling at Quantum-Si
In related news, insider John S. Vieceli sold 21,923 shares of the business's stock in a transaction on Monday, June 23rd. The shares were sold at an average price of $1.61, for a total value of $35,296.03. Following the sale, the insider owned 842,586 shares in the company, valued at approximately $1,356,563.46. The trade was a 2.54% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, CEO Jeffrey Alan Hawkins sold 23,705 shares of the business's stock in a transaction on Monday, June 23rd. The stock was sold at an average price of $1.61, for a total transaction of $38,165.05. Following the completion of the sale, the chief executive officer owned 2,623,011 shares in the company, valued at $4,223,047.71. This represents a 0.90% decrease in their position. The disclosure for this sale can be found here. Insiders sold 54,252 shares of company stock worth $87,346 in the last 90 days. 30.04% of the stock is currently owned by company insiders.
Analysts Set New Price Targets
QSI has been the topic of a number of recent analyst reports. HC Wainwright reissued a "buy" rating and set a $5.50 price target on shares of Quantum-Si in a report on Monday, May 19th. Alliance Global Partners reiterated a "buy" rating on shares of Quantum-Si in a research report on Friday, May 16th. Two research analysts have rated the stock with a Buy rating and one has issued a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $3.48.
Read Our Latest Stock Analysis on Quantum-Si
Quantum-Si Stock Up 0.9%
QSI stock traded up $0.01 during mid-day trading on Friday, hitting $1.08. The company had a trading volume of 3,396,246 shares, compared to its average volume of 6,046,271. The company has a 50-day moving average price of $1.49 and a 200 day moving average price of $1.46. Quantum-Si Incorporated has a 12-month low of $0.61 and a 12-month high of $5.77. The company has a market capitalization of $218.69 million, a price-to-earnings ratio of -1.59 and a beta of 2.85.
Quantum-Si (NASDAQ:QSI - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported ($0.16) earnings per share for the quarter, hitting the consensus estimate of ($0.16). Quantum-Si had a negative net margin of 3,120.14% and a negative return on equity of 44.57%. The company had revenue of $0.59 million for the quarter, compared to analysts' expectations of $1.28 million. As a group, analysts expect that Quantum-Si Incorporated will post -0.65 EPS for the current year.
Quantum-Si Profile
(
Free Report)
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Recommended Stories

Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.